The non-hormonal drug fezolinetant, marketed by Astellas under the name Veoza, alleviates vasomotor symptoms (VMS) – also known as hot flushes and night sweats – that many women suffer from during...
Women's health
Highlights of the programme include tackling the overuse of reliever inhalers for asthma, providing greener respiratory care, managing allergic rhinitis and a look at the use of rescue packs in COPD.
Today's most viewed content
Register to get a FREE issue of Practice Nursing, including articles on asthma, diabetes and much more.
